AstraZeneca Bulk Ingredient
NDC Database

AstraZeneca Bulk Ingredient

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Bulk Ingredient
  • Total Records 14
  • Latest Marketing Date 2026-04-16
  • Data Source FDA
  • First Marketing Date 2005-04-01
All
76
View
Bulk Ingredient
14
View
Drug for Further Processing
62
View
Company Overview

Company

AstraZeneca Bulk Ingredient

Country

United Kingdom

Website

Visit Website

Email

Russell.Gantt@astrazeneca.com

Social Profiles

LinkedIn X / Twitter
Company Snapshot

AstraZeneca Bulk Ingredient

2 Kingdom Street, Paddington, London W2 6BD

United Kingdom

www.astrazeneca.com/ Russell.Gantt@astrazeneca.com View on Map
NDC Records ( 14 records )
2005
01 Apr
Bulk Ingredient NDC: 17228-1991

Nonproprietary Name

Budesonide Micronized

Dosage Form

POWDER

Strength

3.4 kg/3.4kg

Labeler

AstraZeneca AB

Marketing Category

BULK INGREDIENT

17228-1991

Substance

BUDESONIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2005-04-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
07 Nov
Bulk Ingredient NDC: 17228-4610

Nonproprietary Name

Micronized Glycopyrronium Bromide

Dosage Form

POWDER

Strength

1188 g/1188g

Labeler

AstraZeneca AB

Marketing Category

BULK INGREDIENT

17228-4610

Substance

GLYCOPYRROLATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2022-11-07

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
24 Oct
Bulk Ingredient NDC: 17228-5600

Nonproprietary Name

Micronized Glycopyrronium Bromide

Dosage Form

POWDER

Strength

1188 g/1188g

Labeler

AstraZeneca AB

Marketing Category

BULK INGREDIENT

17228-5600

Substance

GLYCOPYRROLATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2022-10-24

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2014
10 Feb
Bulk Ingredient NDC: 17228-7777

Nonproprietary Name

ticagrelor

Dosage Form

POWDER

Strength

35 kg/35kg

Labeler

AstraZeneca AB

Marketing Category

BULK INGREDIENT

17228-7777

Substance

TICAGRELOR

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2014-02-10

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2023
09 Mar
Bulk Ingredient NDC: 17228-9600

Nonproprietary Name

Albuterol Sulfate Micronised Conditioned

Dosage Form

POWDER

Strength

15 kg/15kg

Labeler

AstraZeneca AB

Marketing Category

BULK INGREDIENT

17228-9600

Substance

ALBUTEROL SULFATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2023-03-09

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2023
09 Mar
Bulk Ingredient NDC: 17228-9700

Nonproprietary Name

Budesonide Micronised Co-Suspension APN

Dosage Form

POWDER

Strength

6 kg/6kg

Labeler

AstraZeneca AB

Marketing Category

BULK INGREDIENT

17228-9700

Substance

BUDESONIDE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2023-03-09

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
20 Sep
Bulk Ingredient NDC: 0310-0561

Nonproprietary Name

Micronized Glycopyrronium Bromide

Dosage Form

POWDER

Strength

68 g/68g

Labeler

AstraZeneca Pharmaceuticals LP

Marketing Category

BULK INGREDIENT

0310-0561

Substance

GLYCOPYRROLATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2022-09-20

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2026
16 Apr
Bulk Ingredient NDC: 0310-2021

Nonproprietary Name

Tozorakimab

Dosage Form

LIQUID

Strength

15.6 kg/15.6kg

Labeler

AstraZeneca Pharmaceuticals LP

Marketing Category

BULK INGREDIENT

0310-2021

Substance

TOZORAKIMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2026-04-16

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2021
01 Dec
Bulk Ingredient NDC: 0310-2111

Nonproprietary Name

Sodium Zirconium Cyclosilicate

Dosage Form

POWDER, FOR SUSPENSION

Strength

243 kg/243kg

Labeler

AstraZeneca Pharmaceuticals LP

Marketing Category

BULK INGREDIENT

0310-2111

Substance

SODIUM ZIRCONIUM CYCLOSILICATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2021-12-01

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
04 Feb
Bulk Ingredient NDC: 0310-2830

Nonproprietary Name

benralizumab

Dosage Form

LIQUID

Strength

46.7 kg/46.7kg

Labeler

AstraZeneca Pharmaceuticals LP

Marketing Category

BULK INGREDIENT

0310-2830

Substance

BENRALIZUMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2022-02-04

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2021
30 Jul
Bulk Ingredient NDC: 0310-3000

Nonproprietary Name

anifrolumab

Dosage Form

SOLUTION

Strength

11.7 kg/11.7kg

Labeler

AstraZeneca Pharmaceuticals LP

Marketing Category

BULK INGREDIENT

0310-3000

Substance

ANIFROLUMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2021-07-30

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
04 Feb
Bulk Ingredient NDC: 0310-4113

Nonproprietary Name

palivizumab

Dosage Form

LIQUID

Strength

34.6 kg/34.6kg

Labeler

AstraZeneca Pharmaceuticals LP

Marketing Category

BULK INGREDIENT

0310-4113

Substance

PALIVIZUMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2022-02-04

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2022
04 Feb
Bulk Ingredient NDC: 0310-5500

Nonproprietary Name

durvalumab

Dosage Form

LIQUID

Strength

194.2 kg/194.2kg

Labeler

AstraZeneca Pharmaceuticals LP

Marketing Category

BULK INGREDIENT

0310-5500

Substance

DURVALUMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2022-02-04

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2022
21 Oct
Bulk Ingredient NDC: 0310-5600

Nonproprietary Name

Micronized Glycopyrronium Bromide

Dosage Form

POWDER

Strength

68 g/68g

Labeler

AstraZeneca Pharmaceuticals LP

Marketing Category

BULK INGREDIENT

0310-5600

Substance

GLYCOPYRROLATE

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2022-10-21

End Marketing Date

2026-07-31

Listing Record Certified Through

-

Related Databases
  • FDA Inspections
    77 View
  • EDQM CEP
    1 View
  • KDMF
    0 View
  • Japan DMF
    12 View
  • Eudra GMP
    0 View
  • NDC Database
    76 View
  • FDA Approved Drugs Database
    185 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
14 total
  • Bulk Ingredient
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

17228-1991

Nonproprietary Name

Budesonide Micronized

Labeler

AstraZeneca AB

Dosage Form

POWDER

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit